Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in children and adults . In Canada, its access is overseen by Health Canada. This https://lisdexamfetamine-pharmac647721.blogofoto.com/74729389/vyvanse-in-canada-a-detailed-guide